- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07942181
Passive Mechanical Stiffness Properties and Active Neuromuscular Function of the Foot and Ankle Complex Influence on Running Biomechanics
The Stiff Ankle Project is a prospective, cross-sectional study conducted at UCLouvain within the Institute of Experimental and Clinical Research (IREC/NMSK). The study aims to improve understanding of how the passive mechanical properties and active neuromuscular function of the foot-ankle complex influence running biomechanics, performance, and potential injury risk in healthy runners.
The project is based on the concept that the foot and ankle act both as a spring, capable of storing and releasing energy, and as a lever that contributes to propulsion during running. The primary objective is to integrate measures of tendon stiffness, neuromuscular function, foot morphology, and running biomechanics into a comprehensive framework explaining the role of the foot-ankle complex in running performance and injury mechanisms. A secondary objective is to establish a normative database in healthy runners.
Healthy adult runners aged 18 to 35 years with at least one year of regular running experience and a minimum weekly running volume of 15 km will be recruited. Participants must be free from lower-limb injuries for at least six months. Individuals with a history of Achilles tendon rupture, major foot or ankle surgery, or neurological or musculoskeletal conditions affecting running will be excluded.
Participants will attend three laboratory sessions. Assessments will include measurements of foot morphology, passive stiffness, aerobic fitness, running economy, running biomechanics, muscle activity, and neuromuscular performance. Running tests will be performed both barefoot and shod at individualized speeds. Additional evaluations will include strength, endurance, power, hopping, and jumping tests to establish a comprehensive functional profile of the foot-ankle complex.
The findings are expected to improve understanding of the role of the foot-ankle complex in running and to support the development of individualized approaches for performance enhancement, injury prevention, and rehabilitation.
Studieoversikt
Status
Forhold
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Thomas Hansoulle, Msc
- Telefonnummer: +32493691297
- E-post: thomas.hansoulle@uclouvain.be
Studiesteder
-
-
Brussels Capital
-
Wolluwe-Saint-Lambert, Brussels Capital, Belgia, 1200
- Rekruttering
- NMSK lab
-
Ta kontakt med:
- Thomas Hansoulle, Msc
- Telefonnummer: +32493691297
- E-post: thomas.hansoulle@uclouvain.be
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age between 18 and 60 years
- At least 1 year of regular running experience (minimum weekly practice)
- Weekly running volume of at least 15 km
- Free from lower-limb injury for at least 6 months prior to participation
Exclusion Criteria:
- Activity level below Tier 1 or above Tier 3 according to the McKay performance classification
- History of Achilles tendon rupture
- History of major foot or ankle surgery
- Chronic systemic musculoskeletal disorders
- Neurological conditions likely to affect gait or running performance
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Screening
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Healthy runners
Healthy recreational and competitive runners aged 18 to 35 years with at least one year of regular running experience and a minimum weekly running volume of 15 km. Participants are free from lower-limb injury for at least six months prior to enrollment. |
An incremental treadmill test to volitional exhaustion will first be conducted. The test will start at 8 km·h-¹ with speed increasing by 1 km·h-¹ every 3 minutes. Capillary blood samples will be collected at the end of each stage to measure blood lactate concentration. Respiratory gas exchange will be continuously recorded throughout the test to determine ventilatory thresholds and maximal oxygen uptake. LT1 will be identified as the first sustained increase in blood lactate concentration above baseline values. LT2 will be determined using the modified D-max method. A third-order polynomial function will be fitted to the lactate-velocity relationship, and LT2 will be defined as the point of maximal perpendicular distance between the fitted curve and the straight line connecting the first systematic rise in blood lactate concentration and the final lactate value.
Andre navn:
Participants will undergo a running biomechanics assessment on an instrumented treadmill at three individualized speeds determined from their lactate thresholds (LT1 and LT2). Running trials will be performed under shod and barefoot conditions. Three-dimensional motion capture, ground reaction forces, plantar pressure distribution, and metabolic measurements will be collected to characterize running mechanics, foot-ankle kinetics, and running economy. Participants will undergo a comprehensive neuromuscular assessment of the foot-ankle complex. The testing battery will include maximal voluntary isometric strength of the plantar flexors, dorsiflexors, invertors, evertors, and toe flexors; plantar flexor power; muscular endurance through a heel-rise test; and reactive muscle function through hopping and rebound jump tests. Additional countermovement and drop jump assessments will be performed to characterize lower-limb neuromuscular capacities. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Foot-Ankle Neuromuscular strength
Tidsramme: Throughout the entire study, approximately during 13 months
|
Maximal strength will be assessed through Maximal Voluntary Isometric Contractions. After two familiarization trials, participants will perform three five-second maximal voluntary isometric contractions (MVICs) with 20 seconds of rest between each attempt. Participants will be instructed to progressively increase force during the first two seconds to avoid an early exaggerated peak before reaching a maximal plateau. If the difference between the lowest and highest values across the three trials exceeds 20%, additional trials will be performed until the three most recent trials differ by less than 20%; isolated high values that are clearly not reproducible will be disregarded for this consistency criterion. The mean of the two highest torque values (Newtons) will be normalized to bodyweight and retained for analysis. Strength of plantar flexors, dorsiflexors, evertors, invertors, toe flexors and hallow flexors will be assessed. |
Throughout the entire study, approximately during 13 months
|
|
Foot-Ankle Neuromuscular endurance
Tidsramme: Throughout the entire study, approximately during 13 months
|
Plantar flexors endurance will be assessed with the heel rise test (HRT) as described by Hebert-Losier et al. (Hébert-Losier et al., 2017). Participants will stand on the tested limb with the knee fully extended, while the contralateral limb will be flexed and do not contact the ground. Light fingertip support will be permitted for balance. Participants will perform repeated heel raises at a cadence of 0.5 Hz, rising to maximum heel height and returning to the starting position in a controlled manner. The test will be terminated when the participant could no longer maintain the required movement amplitude or rhythm, or when compensatory strategies are observed. The total number of correctly performed repetitions will be recorded for analysis. |
Throughout the entire study, approximately during 13 months
|
|
Pantar flexors power
Tidsramme: Throughout the entire study, approximately during 13 months
|
Plantar-flexor power will be assessed using a step positioned on a force plate. participants begin at the top of the raise (heel as high as possible) and move their heel down (eccentric) and up (concentric) as fast and strong as possible. During this test, participants will wear a weighted vest corresponding to 30% of their body mass. The mean concentric-phase power across the three trials will be recorded for analysis (Bidois et al., 2026; Silbernagel et al., 2006). |
Throughout the entire study, approximately during 13 months
|
|
Foot-ankle reactive strength
Tidsramme: Throughout the entire study, approximately during 13 months
|
Foot and ankle reactive strength will be assessed by a foot-ankle rebound jump test as described by Tourillon et al. 2024 (Tourillon et al., 2024). Participants will be asked to jump as high as possible while keeping their lower limbs fully straight, and to push against the ground as quickly as possible with only a plantarflexion of the ankle and the metatarsophalangeal joint during 8 jumps. Data will be recorded on a force platform (VALD) enabling calculation of reactive strength index. Ground contact time will be defined as the interval between landing and take-off using a 20 N force threshold and jump height will be calculated from flight time. Reactive strength index will be calculated as jump height divided by ground contact time (Lloyd et al., 2009). Three trials will be performed with 60 s rest; one trial has been shown to provide reliable estimates of performance (Stratford et al., 2021). |
Throughout the entire study, approximately during 13 months
|
|
Ankle braking power
Tidsramme: Throughout the entire study, approximately during 13 months
|
Braking ankle power will be assessed through inverse dynamics while the participants will be shod running at 10km.h-1, velocity at lactate threshold 1, velocity at lactate threshold 2 and velocity at 50% inbetween lactate threshold.. Plug-in Gait model will be used for markers placements. Braking phase is defined as the first part of the contact phase while antero-posterior forces are negative. Peak negative power and negative power impulse will be kept for analysis. |
Throughout the entire study, approximately during 13 months
|
|
Ankle Propulsive power
Tidsramme: Throughout the entire study, approximately during 13 months
|
Propulsive ankle power will be assessed through inverse dynamics while the participants will be shod running at 10km.h-1, velocity at lactate threshold 1, velocity at lactate threshold 2 and velocity at 50% inbetween lactate threshold.. Plug-in Gait model will be used for markers placements. Propulsive phase is defined as the second part of the contact phase while antero-posterior forces are positive. Peak positive power and positive power impulse will be kept for analysis. |
Throughout the entire study, approximately during 13 months
|
|
Late stance foot stiffness
Tidsramme: Throughout the entire study, approximately during 13 months
|
This methodology is similar to Farris et al. 2019. While running at 10kmh.h-1, velocity at lactate threshold 1, velocity at lactate threshold 2 and velocity at 50% inbetween lactate threshold. Reflective markers will be attached following Instituto Orthopaedic Rizzoli (IOR) gait model. Metatarsus - clacaneus angle will represent the compression of the longitudinal arch. The angle of the MTP will be the orientation of the hallux segment relative to the metatarsal segment. Inverse dynamics will be used to calculate mid-foot segment after the center of pressure has progressed over the proximal end of the mid foot. Foot power will be calculated following Takahshi et al.2017. |
Throughout the entire study, approximately during 13 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Lower limb reactive strength
Tidsramme: Day 3
|
The hopping test will be performed (Goodwin et al., 2020). Participants will complete a three 30 second bouts of bilateral hopping test at a controlled cadence of 132 jumps per minute (2.2 Hz). An audible metronome will provide the rhythm to ensure consistency, and participants will be instructed to maintain minimal knee flexion, upright posture, and forefoot contact throughout. Ground reaction forces will be recorded using dual force plates (VALD). |
Day 3
|
|
Drop jump force-velocity profiling
Tidsramme: Throughout the entire study, approximately during 13 months
|
Force-velocity profiling will be assessed using drop jumps (DJ). Participants will perform DJs from five standardized heights (10, 20, 30, 40, and 50 cm), with the order of heights randomized to minimize sequencing effects. Ground reaction forces will be sampled at 1,000 Hz using dual force plates (VALD). From each DJ, velocity at contact, jump height, ground contact time (GCT), and reactive strength index (RSI) will be extracted. Phase-specific mean force and velocity values from the eccentric (landing) and concentric (take-off) phases will be used to compute individualized force-velocity relationships. This method, adapted from Moir et al. 2018, has demonstrated excellent test-retest reliability (ICC = 0.84-0.99) and provides a functional index of lower-limb explosive capacity (G. Moir et al., 2018). |
Throughout the entire study, approximately during 13 months
|
|
Running economy
Tidsramme: Throughout the entire study, approximately during 13 months
|
he net metabolic cost (NMC) of running will be assessed for two 3-minute treadmill bouts performed at velocity at lactate threshold 1, velocity at lactate threshold 2 of each participant. All trials will be conducted on a motorized treadmill in a temperature- and humidity-controlled laboratory environment. Before the running bouts, participants will complete a 2-minute standing trial to establish their baseline metabolic demand. Breath-by-breath oxygen uptake (VO₂) and carbon dioxide production (VCO₂) will be continuously measured using a calibrated metabolic cart (Ergocard CPX, Medisoft). To ensure the analysis reflects steady-state exercise, only the final 60 seconds of each 3-minute running bout will be used for averaging VO₂ and VCO₂ values. Energy expenditure will be calculated usinghe Weir equation, which converts gas exchange data into caloric output (3.941×VO2)+(1.106×VCO2)(3.941 × VO₂) + (1.106 × VCO₂)(3.941×VO2)+(1.106×VCO2), with VO₂ and VCO₂ expressed in liters per minute |
Throughout the entire study, approximately during 13 months
|
|
Lactate thresholds
Tidsramme: Throughout the entire study, approximately during 13 months
|
an incremental treadmill test to volitional exhaustion will first be conducted. The test will start at 8 km·h-¹ with speed increasing by 1 km·h-¹ every 3 minutes. Capillary blood samples will be collected at the end of each stage to measure blood lactate concentration. Respiratory gas exchange will be continuously recorded throughout the test to determine ventilatory thresholds and maximal oxygen uptake. LT1 will be identified as the first sustained increase in blood lactate concentration above baseline values. LT2 will be determined using the modified D-max method. A third-order polynomial function will be fitted to the lactate-velocity relationship, and LT2 will be defined as the point of maximal perpendicular distance between the fitted curve and the straight line connecting the first systematic rise in blood lactate concentration and the final lactate value (Chalmers et al., 2015). |
Throughout the entire study, approximately during 13 months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- The Stiff Ankle Project
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .